Institute of Immunology director Vedran Čardžić said that the construction of the factory, a project worth about HRK 100 million, should start at the end of 2022 or early 2023.
The factory’s main product would be vaccines but there are plans to launch the production of antivenom for the duration of preparations for construction work and regulation of the related legal matters.
“We will launch the production of antivenom during preparations for the construction of the new factory. That unit will be part of the new factory which will focus on vaccines against children’s diseases (measles). Those vaccines used to be produced by the Institute of Immunology and the state owns the master seeds which international experts say are the best because they give the best vaccination results owing to their properties,” said Čardžić.
This is expected to be followed by the launch of production of plasma-derived products and potential adoption of technologies for the production of newer virus vaccines in cooperation with partners, which is being negotiated, he said.
Minister Beroš said that this spring Croatia was faced with a shortage of antivenom, and even though the problem was quickly solved, he noted that as a tourist destination, Croatia should be able to rely on its own antivenom production.
He noted that antivenom production was expected to start before the next tourist season, adding that current employees of the Institute of Immunology would make up the core of the research staff at the new factory.
Čardžić also pointed to the need to attract new experts, noting that he would contact universities to inquire about successful students nearing graduation who would be interested in working at the Institute of Immunology.
Sveta Nedelja Mayor Dario Zurovec expressed hope the project would be a sustainable model of public-private partnership, announcing support by local authorities.
For more on politics, CLICK HERE.
